Skip to main content

Packaging, labelling and marketing of pharmaceuticals has evolved rapidly in India, with concerns about ‘deceptive similarity’ at the helm. Our Pharma Dossier (Vol. 1) discusses trade mark jurisprudence in light of the primary factor – the consumer.

Whereas differentiation on the basis of a name may have become more constrictive, creative use of unconventional marks and branding exercises by pharmaceutical companies has aided the creation of unique identities. Useful, with the rate e-pharmacies are disrupting traditional distribution models.

 

To read more, contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
Thought Leadership
May 29, 2025

‘First published on Lexology’ By: Sandhya Singh, Sampada Kapoor and Kritika Gandhi Trademarks play a pivotal role in distinguishing the goods or services

Heir of the Family Trademarks
Thought Leadership
May 15, 2025

‘First published on India Business Law Journal’ By: Pravin Anand, Dr. Ajai Garg and Alvin Antony The ascendancy of large language models (LLMs) has

Navigating the AI frontier: India’s sovereign LLM quest
Thought Leadership
Apr 30, 2025

‘First published on Asia IP’ By: Prachi Agarwal and Manan Mondal In a significant ruling, the Division Bench of the Delhi High Court in Wipro Enterprises

Senior user versus junior user: Delhi High Court confirms passing off in a trademark dispute
Thought Leadership
Apr 29, 2025

‘First published on IP Stars’ By: Safir Anand, Omesh Puri and Abhishek Paliwal As the world changes and technology grows fast, the way we think about

The future of trademarks: shaping tomorrow’s brand identity